Stock XRTX XORTX THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Market Closed - Toronto S.E.
Other stock markets
 03:56:49 2024-05-01 pm EDT 		5-day change 1st Jan Change
3.53 CAD +0.86% Intraday chart for XORTX Therapeutics Inc. -10.63% +21.72%
Apr. 22 XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal MT
Apr. 08 XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
XORTX Reprices Warrants Issued in Connection with Previous Private Placements
AQ
XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal
MT
XORTX Announces Publication of Key Research in ADPKD
AQ
Money Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NASDAQ:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future
AW
Money Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NAS:XRTX) (VAN:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future
AQ
XORTX Welcomes New Member to the Board of Directors
AQ
XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors
CI
XORTX Announces Participation in Spring 2024 Investor Conferences
AQ
XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K
PU
XORTX Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
XORTX Announces New Clinical Advisory Board Member
AQ
XORTX Announces New Clinical Advisory Board Member
AQ
XORTX Therapeutics Inc. Appoints Ronald Perrone as Clinical Advisory Board
CI
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
AQ
XORTX Therapeutics Provides Update
MT
XORTX Therapeutics Brief: Has Highlighted "Achievements" of 2023 and Preparations for Registration Clinical Trial
MT
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
AQ
XORTX Therapeutics : Investor Presentation
PU
MONEY TALK RADIO with XORTX Therapeutics Inc. (NAS:XRTX) Dr. Allen Davidoff Explains Advanced Drug Therapy for Kidney Disease and Diabetes
AQ
MONEY TALK RADIO with XORTX Therapeutics Inc. (NASDAQ:XRTX) Dr. Allen Davidoff Explains Advanced Drug Therapy for Kidney Disease and Diabetes
AW
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XRTX Stock
  4. News XORTX Therapeutics Inc.